XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.99

+1.5%

Jan 29 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (12450)	12/15/1999 12:38:00 AM
From: Bluegreen	Read Replies (2) of 17367

From the Danish study>>>>>>>>>>>>The effects of CETP on atherogenesis are currently unpredictable, and they are likely to depend on the metabolic context. However, the presence of specific polymorphisms in the CETP gene may be of clinical importance, and CETP should be considered among the factors relevant for differentiation of dyslipidemic syndromes associated with susceptibility to and protection from atherosclerotic disease.<<<<<<<<<<<<<<<<<< "Polymorphisms in the CETP gene" Hmmmmmmm Now how can antibodies tell the difference between CETP and BPI???? Isn't inflammation part of CAD? What about theories of bugs being part of CAD? WORLDWIDE INTEREST IN BPI!!!!! WHY?????????? WILL IT EVER GET TO MARKET???????? HARRY S DENT................Did he see all of these things in BPI? Harry S Dent.........A Genius???? What else might he see in Xoma? And Xoma is sooooo quiet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next